Increase of histaminergic tuberomammillary neurons in narcolepsy

Annals of Neurology

Volumn 74, Issue 6, 2013, Pages 794-804

  Valko, Philipp O ^a,b   Gavrilov, Yury V ^a,b,c   Yamamoto, Mihoko ^a   Reddy, Hasini ^a   Haybaeck, Johannes ^d   Mignot, Emmanuel ^e   Baumann, Christian R ^a,b   Scammell, Thomas E ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNORPHIN; HISTAMINE; HISTIDINE DECARBOXYLASE; MELANIN CONCENTRATING HORMONE; OREXIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CATAPLEXY; CELL COUNT; CEREBROSPINAL FLUID; DAYTIME SOMNOLENCE; HISTAMINE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NARCOLEPSY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROMOTER REGION; RELIABILITY; TRANSGENIC MOUSE; TUBEROMAMMILLARY NUCLEUS; WILD TYPE;

AGED; AGED, 80 AND OVER; ANIMALS; CELL COUNT; DISEASE MODELS, ANIMAL; FEMALE; HISTAMINE; HUMANS; HYPOTHALAMIC AREA, LATERAL; HYPOTHALAMIC HORMONES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MELANINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MIDDLE AGED; NARCOLEPSY; NEURONS; NEUROPEPTIDES; NUCLEAR PROTEINS; PITUITARY HORMONES; TRANSCRIPTION FACTORS;

EID: 84892147937     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24019     Document Type: Article

References (61)

1. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6: 991-997.
2. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27: 469-474.
3. Nishino S, Ripley B, Overeem S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355: 39-40.
4. Haas HL, Sergeeva OA, Selbach O,. Histamine in the nervous system. Physiol Rev 2008; 88: 1183-1241.
5. Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998; 18: 9996-10015.
6. Eriksson KS, Sergeeva O, Brown RE, Haas HL,. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 2001; 21: 9273-9279.
7. Torrealba F, Yanagisawa M, Saper CB,. Colocalization of orexin A and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 2003; 119: 1033-1044.
8. Mochizuki T, Arrigoni E, Marcus JN, et al. Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice. Proc Natl Acad Sci U S A 2011; 108: 4471-4476.
9. Ko EM, Estabrooke IV, McCarthy M, Scammell TE,. Wake-related activity of tuberomammillary neurons in rats. Brain Res 2003; 992: 220-226.
10. Takahashi K, Lin JS, Sakai K,. Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. J Neurosci 2006; 26: 10292-10298.
11. Zeitzer JM, Kodama T, Buckmaster CL, et al. Time-course of cerebrospinal fluid histamine in the wake-consolidated squirrel monkey. J Sleep Res 2012; 21: 189-194.
12. Roehrs TA, Tietz EI, Zorick FJ, Roth T,. Daytime sleepiness and antihistamines. Sleep 1984; 7: 137-141.
13. Lin JS,. Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons. Sleep Med Rev 2000; 4: 471-503.
14. Huang ZL, Qu WM, Li WD, et al. Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci U S A 2001; 98: 9965-9970.
15. Nishino S, Sakurai E, Nevsimalova S, et al. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep 2009; 32: 175-180.
16. Kanbayashi T, Kodama T, Kondo H, et al. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep 2009; 32: 181-187.
17. Bassetti CL, Baumann CR, Dauvilliers Y, et al. Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin. J Sleep Res 2010; 19: 620-623.
18. Ohtsu H, Watanabe T,. New functions of histamine found in histidine decarboxylase gene knockout mice. Biochem Biophys Res Commun 2003; 305: 443-447.
19. Crocker A, España RA, Papadopoulou M, et al. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 2005; 65: 1184-1188.
20. Scammell TE, Matheson JK, Honda M, et al. Coexistence of narcolepsy and Alzheimer's disease. Neurobiol Aging 2012; 33: 1318-1319.
21. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999; 98: 437-451.
22. Mochizuki T, Crocker A, McCormack S, et al. Behavioral state instability in orexin knock-out mice. J Neurosci 2004; 24: 6291-6300.
23. Hara J, Beuckmann CT, Nambu T, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001; 30: 345-354.
24. Kantor S, Mochizuki T, Janisiewicz AM, et al. Orexin neurons are necessary for the circadian control of REM sleep. Sleep 2009; 32: 1127-1134.
25. Chou TC, Lee CE, Lu J, et al. Orexin (hypocretin) neurons contain dynorphin. J Neurosci 2001; 21: RC168.
26. Blouin AM, Thannickal TC, Worley PF, et al. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy. Neurology 2005; 65: 1189-1192.
27. Pissios P, Ozcan U, Kokkotou E, et al. Melanin concentrating hormone is a novel regulator of islet function and growth. Diabetes 2007; 56: 311-319.
28. Mizuguchi J, Yabumoto M, Imamura I, et al. Immuno-cross-reactivity of histidine and dopa decarboxylases. Biochem Biophys Res Commun 1990; 173: 1299-1303.
29. Krolewski DM, Medina A, Kerman IA, et al. Expression patterns of corticotrophin-releasing factor, arginine vasopressin, histidine decarboxylase, melanin-concentrating hormone, and orexin genes in the human hypothalamus. J Comp Neurol 2010; 518: 4591-4611.
30. Airaksinen MS, Paetau A, Paljärvi L, et al. Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neuroscience 1991; 44: 465-481.
31. Gundersen HJ, Jensen EB,. The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987; 147: 229-263.
32. West MJ,. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci 1999; 22: 51-61.
33. Gundersen HJ,. The nucleator. J Microsc 1988; 151: 3-21.
34. Burgess CR, Scammell TE,. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci 2012; 32: 12305-12311.
35. Sakurai T,. Orexin deficiency and narcolepsy. Curr Opin Neurobiol 2013; 23: 760-766.
36. Panula P, Yang HY, Costa E,. Histamine-concentrating neurons in the rat hypothalamus. Proc Natl Acad Sci U S A 1984; 81: 2572-2576.
37. Watanabe T, Taguchi Y, Shiosaka S, et al. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 1984; 295: 13-25.
38. Karlstedt K, Nissinen M, Michelsen KA, Panula P,. Multiple sites of L-histidine decarboxylase expression in mouse suggest novel developmental functions for histamine. Dev Dyn 2001; 221: 81-91.
39. John J, Thannickal TC, McGregor R, et al. Greatly increased numbers of histamine cells in human narcolepsy with cataplexy. Ann Neurol (in press).
40. Kalogiannis M, Grupke SL, Potter PE, et al. Narcoleptic orexin receptor knockout mice express enhanced cholinergic properties in laterodorsal tegmental neurons. Eur J Neurosci 2010; 32: 130-142.
41. Sallmen T, Beckman AL, Stanton TL, et al. Major changes in the brain histamine system of the ground squirrel citellus lateralis during hibernation. J Neurosci 1999; 19: 1824-1835.
42. Asmus SE, Parsons S, Landis SC,. Developmental changes in the transmitter properties of sympathetic neurons that innervate the periosteum. J Neurosci 2000; 20: 1495-1504.
43. Bezin L, Marcel D, Desgeorges S, et al. Singular subsets of locus coeruleus neurons may recover tyrosine hydroxylase phenotype transiently expressed during development. Brain Res Mol Brain Res 2000; 76: 275-281.
44. Molina-Hernández A, Díaz NF, Arias-Montaño JA,. Histamine in brain development. J Neurochem 2012; 122: 872-882.
45. Zecharia AY, Yu X, Götz T, et al. GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-induced loss of consciousness. J Neurosci 2012; 32: 13062-13075.
46. Walker AK, Park WM, Chuang JC, et al. Characterization of gastric and neuronal histaminergic populations using a transgenic mouse model. PLoS One 2013; 8: e60276.
47. Dulcis D, Jamshidi P, Leutgeb S, Spitzer NC,. Neurotransmitter switching in the adult brain regulates behavior. Science 2013; 340: 449-453.
48. Ishizuka T, Sakamoto Y, Sakurai T, Yamatodani A,. Modafinil increases histamine release in the anterior hypothalamus of rats. Neurosci Lett 2003; 339: 143-146.
49. Horner WE, Johnson DE, Schmidt AW, Rollema H,. Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex. Eur J Pharmacol 2007; 558: 96-97.
50. Sundvik M, Kudo H, Toivonen P, et al. The histaminergic system regulates wakefulness and orexin/hypocretin neuron development via histamine receptor H1 in zebrafish. FASEB J 2011; 25: 4338-4347.
51. Ishii T,. Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia. Acta Neuropathol 1966; 6: 181-187.
52. Saper CB, German DC,. Hypothalamic pathology in Alzheimer's disease. Neurosci Lett 1987; 74: 364-370.
53. Nakamura S, Takemura M, Ohnishi K, et al. Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease. Neurosci Lett 1993; 151: 196-199.
54. Kang JE, Lim MM, Bateman RJ, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009; 326: 1005-1007.
55. Shan L, Swaab DF, Bao AM,. Neuronal histaminergic system in aging and age-related neurodegenerative disorders. Exp Gerontol 2013; 48: 603-607.
56. Dauvilliers Y, Arnulf I, Mignot E,. Narcolepsy with cataplexy. Lancet 2007; 369: 499-511.
57. Brisbare-Roch C, Dingemanse J, Koberstein R, et al. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 2007; 13: 150-155.
58. Croyal M, Dauvilliers Y, Labeeuw O, et al. Histamine and tele-methylhistamine quantification in cerebrospinal fluid from narcoleptic subjects by liquid chromatography tandem mass spectrometry with precolumn derivatization. Anal Biochem 2011; 409: 28-36.
59. Dauvilliers Y, Delallée N, Jaussent I, et al. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions. Sleep 2012; 35: 1359-1366.
60. Lin JS, Dauvilliers Y, Arnulf I, et al. An inverse agonist of the histamine H (3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol Dis 2008; 30: 74-83.
61. John J, Wu MF, Boehmer LN, Siegel JM,. Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior. Neuron 2004; 42: 619-634.